Free Trial

Select Medical (NYSE:SEM) Hits New 1-Year High - Still a Buy?

Select Medical logo with Medical background

Select Medical Holdings Co. (NYSE:SEM - Get Free Report) shares hit a new 52-week high on Monday . The stock traded as high as $40.98 and last traded at $40.35, with a volume of 63158 shares changing hands. The stock had previously closed at $39.27.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on SEM. Benchmark reaffirmed a "buy" rating and issued a $48.00 target price on shares of Select Medical in a research note on Friday, November 1st. Royal Bank of Canada raised their target price on Select Medical from $40.00 to $47.00 and gave the stock an "outperform" rating in a research report on Monday, November 4th. StockNews.com downgraded Select Medical from a "buy" rating to a "hold" rating in a research note on Tuesday, November 5th. Finally, Bank of America initiated coverage on Select Medical in a report on Tuesday, August 20th. They issued a "buy" rating and a $42.00 target price for the company. Two research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, Select Medical presently has an average rating of "Moderate Buy" and a consensus target price of $40.75.

Check Out Our Latest Stock Analysis on Select Medical

Select Medical Stock Up 2.4 %

The business has a 50-day simple moving average of $34.48 and a 200-day simple moving average of $34.44. The company has a market cap of $5.20 billion, a PE ratio of 18.77, a P/E/G ratio of 2.04 and a beta of 1.42. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 1.37.

Select Medical (NYSE:SEM - Get Free Report) last announced its earnings results on Thursday, October 31st. The health services provider reported $0.43 EPS for the quarter, beating analysts' consensus estimates of $0.36 by $0.07. Select Medical had a return on equity of 15.99% and a net margin of 3.97%. The business had revenue of $1.76 billion during the quarter, compared to analysts' expectations of $1.74 billion. During the same quarter in the prior year, the firm earned $0.46 earnings per share. The business's revenue was up 5.7% compared to the same quarter last year. Equities research analysts anticipate that Select Medical Holdings Co. will post 2.16 EPS for the current year.

Select Medical Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, November 26th. Investors of record on Wednesday, November 13th will be issued a $0.125 dividend. The ex-dividend date is Wednesday, November 13th. This represents a $0.50 annualized dividend and a dividend yield of 1.24%. Select Medical's dividend payout ratio is presently 23.36%.

Institutional Investors Weigh In On Select Medical

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Foundry Partners LLC increased its holdings in shares of Select Medical by 3.6% in the third quarter. Foundry Partners LLC now owns 245,860 shares of the health services provider's stock valued at $8,573,000 after purchasing an additional 8,561 shares during the last quarter. Intech Investment Management LLC grew its position in Select Medical by 39.7% in the third quarter. Intech Investment Management LLC now owns 24,720 shares of the health services provider's stock worth $862,000 after acquiring an additional 7,021 shares during the period. Connor Clark & Lunn Investment Management Ltd. purchased a new position in Select Medical in the third quarter worth approximately $1,320,000. Jennison Associates LLC purchased a new position in Select Medical in the third quarter worth approximately $625,000. Finally, Segall Bryant & Hamill LLC purchased a new position in Select Medical in the third quarter worth approximately $2,767,000. Institutional investors and hedge funds own 89.48% of the company's stock.

Select Medical Company Profile

(Get Free Report)

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.

See Also

Should you invest $1,000 in Select Medical right now?

Before you consider Select Medical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Select Medical wasn't on the list.

While Select Medical currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines